About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Prkcbtm1Tara
targeted mutation 1, Alexander Tarakhovsky
MGI:2183193
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Prkcbtm1Tara/Prkcbtm1Tara B6.Cg-Prkcbtm1Tara MGI:4821390
hm2
Prkcbtm1Tara/Prkcbtm1Tara involves: 129 MGI:3041947
hm3
Prkcbtm1Tara/Prkcbtm1Tara involves: 129 * C57BL/6J MGI:4821149
hm4
Prkcbtm1Tara/Prkcbtm1Tara involves: C57BL/6 MGI:3041948
ht5
Prkcbtm1Tara/Prkcb+ involves: 129 MGI:3041951


Genotype
MGI:4821390
hm1
Allelic
Composition
Prkcbtm1Tara/Prkcbtm1Tara
Genetic
Background
B6.Cg-Prkcbtm1Tara
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcbtm1Tara mutation (0 available); any Prkcb mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• intima/media ratio is lower 28 days after endothelial denudation of the femoral artery than in controls

homeostasis/metabolism
• intima/media ratio is lower 28 days after endothelial denudation of the femoral artery than in controls




Genotype
MGI:3041947
hm2
Allelic
Composition
Prkcbtm1Tara/Prkcbtm1Tara
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcbtm1Tara mutation (0 available); any Prkcb mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• after stimulation with antibody to IgM, compared to controls
• reduced basal proliferation in the absence of stimuli, compared to controls
• reduced proliferation in response to LPS
• combined treatment with antibody to CD40 and with IL-4 provoked equally strong proliferation, compared to controls
• combined treatment with phorbol ester, PdBU, and calcium ionophore, ionomycin, provoked equally strong proliferation, compared to controls
• although B cells were present in lymph nodes and spleen, absolute numbers of splenic B cells were reduced compared to wild-type controls
• normal frequency and absolute number of pre-B (IgM-, B220lo, CD43-) and mature B cells (IgM+, B220hi) in bone marrow
• reduced numbers of B-1 (CD23-, IgM+) cells in peritoneal cavity
• reduced numbers of B-1a (CD5+, IgM+) cells in peritoneal cavity
• IgG3 reduced

immune system
N
• normal thymus size and cellularity, contained normal ratios of double positive (CD4+CD8+) and single positive (CD4+ or CD8+) cells
• single positive (CD4+ or CD8+) T cells present in spleen and lymph nodes at frequency similar to wild-type controls
• normal T cell proliferation
• after stimulation with antibody to IgM, compared to controls
• reduced basal proliferation in the absence of stimuli, compared to controls
• reduced proliferation in response to LPS
• combined treatment with antibody to CD40 and with IL-4 provoked equally strong proliferation, compared to controls
• combined treatment with phorbol ester, PdBU, and calcium ionophore, ionomycin, provoked equally strong proliferation, compared to controls
• although B cells were present in lymph nodes and spleen, absolute numbers of splenic B cells were reduced compared to wild-type controls
• normal frequency and absolute number of pre-B (IgM-, B220lo, CD43-) and mature B cells (IgM+, B220hi) in bone marrow
• reduced numbers of B-1 (CD23-, IgM+) cells in peritoneal cavity
• reduced numbers of B-1a (CD5+, IgM+) cells in peritoneal cavity
• failed to mount detectable humoral response to T cell-independent antigen (NP-Ficoll), but not T cell-dependent antigen (NP-chicken gamma-globulin conjugate)
• reduced primary antibody responses to hapten (NP) and carrier (chicken gamma-globulin), compared to controls
• reduced secondary immune response to chicken gamma-globulin, but not hapten (NP), compared to controls
• IgG3 reduced

cellular
• after stimulation with antibody to IgM, compared to controls
• reduced basal proliferation in the absence of stimuli, compared to controls
• reduced proliferation in response to LPS
• combined treatment with antibody to CD40 and with IL-4 provoked equally strong proliferation, compared to controls
• combined treatment with phorbol ester, PdBU, and calcium ionophore, ionomycin, provoked equally strong proliferation, compared to controls




Genotype
MGI:4821149
hm3
Allelic
Composition
Prkcbtm1Tara/Prkcbtm1Tara
Genetic
Background
involves: 129 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcbtm1Tara mutation (0 available); any Prkcb mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• CCK-8-treated mice exhibit a normal increase in AMPA excitatory postsynaptic currents




Genotype
MGI:3041948
hm4
Allelic
Composition
Prkcbtm1Tara/Prkcbtm1Tara
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcbtm1Tara mutation (0 available); any Prkcb mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• normal passive avoidance
• normal sensory responses to foot shock, hotplate
• normal motor responses on rotarod and in open field
• deficits in contextual fear conditioning
• deficits in cued fear conditioning

nervous system
N
• normal brain anatomy
• normal hippocampal synaptic transmission at Schaffer collateral synapses
• normal paired pulse facilitation
• normal long term potentiation




Genotype
MGI:3041951
ht5
Allelic
Composition
Prkcbtm1Tara/Prkcb+
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkcbtm1Tara mutation (0 available); any Prkcb mutation (37 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• compared to controls, reduced humoral response to T cell-independent antigen (NP-Ficoll), but not T cell-dependent antigen (NP-chick gamma-globulin conjugate)
• greater response than homozygous mutant mice, suggestive of gene dosage effects
• IgG3 slightly reduced, compared to controls, but greater than homozygous mutant mice, suggestive of gene dosage phenomenon
• slightly reduced, compared to controls, but greater than homozygous mutant mice, suggestive of gene dosage phenomenon

hematopoietic system
• IgG3 slightly reduced, compared to controls, but greater than homozygous mutant mice, suggestive of gene dosage phenomenon
• slightly reduced, compared to controls, but greater than homozygous mutant mice, suggestive of gene dosage phenomenon





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory